This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
A Baddeley (1996). The fractionation of working memory. Proceedings of the National Academy of Sciences USA 93, 13468–13472.
MJ Brammer , ET Bullmore , A Simmons , SC Williams , PM Grasby , RJ Howard , PW Woodruff , S Rabe-Hesketh (1997). Generic brain activation mapping in functional magnetic resonance imaging: a nonparametric approach. Magnetic Resonance Imaging 15, 763–770.
DJ Bridgett , ME Walker (2006). Intellectual functioning in adults with ADHD: a meta-analytic examination of full scale IQ differences between adults with and without ADHD. Psychological Assessment 18, 1–14.
E Bullmore , C Long , J Suckling , J Fadili , G Calvert , F Zelaya , TA Carpenter , M Brammer (2001). Colored noise and computational inference in neurophysiological (fMRI) time series analysis: resampling methods in time and wavelet domains. Human Brain Mapping 12, 61–78.
ET Bullmore , MJ Brammer , S Rabe-Hesketh , VA Curtis , RG Morris , SC Williams , T Sharma , PK McGuire (1999). Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI. Human Brain Mapping 7, 38–48.
SA Bunge , SB Wright (2007). Neurodevelopmental changes in working memory and cognitive control. Current Opinion in Neurobiology 17, 243–250.
FP Bymaster , JS Katner , DL Nelson , SK Hemrick-Luecke , PG Threlkeld , JH Heiligenstein , SM Morin , DR Gehlert , KW Perry (2002). Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27, 699–711.
SR Chamberlain , N Del Campo , J Dowson , U Muller , L Clark , TW Robbins , BJ Sahakian (2007). Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biological Psychiatry 62, 977–984.
SR Chamberlain , A Hampshire , U Muller , K Rubia , N Del Campo , K Craig , R Regenthal , J Suckling , JP Roiser , JE Grant , ET Bullmore , TW Robbins , BJ Sahakian (2009). Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biological Psychiatry 65, 550–555.
A Christakou , CM Murphy , K Chantiluke , AI Cubillo , AB Smith , V Giampietro , E Daly , C Ecker , D Robertson ; MRC AIMS consortium, DG Murphy , K Rubia (2013). Disorder-specific functional abnormalities during sustained attention in youth with attention deficit hyperactivity disorder (ADHD) and with autism. Molecular Psychiatry 18, 236–244.
EA Crone , C Wendelken , S Donohue , L van Leijenhorst , SA Bunge (2006). Neurocognitive development of the ability to manipulate information in working memory. Proceedings of the National Academy of Sciences USA 103, 9315–9320.
A Cubillo , R Halari , A Smith , E Taylor , K Rubia (2012 a). A review of fronto-striatal and frontocortical brain abnormalities in children and adults with attention deficit hyperactivity disorder (ADHD) and new evidence for dysfunction in adults with ADHD during motivation and attention. Cortex 48, 194–215.
JN Epstein , BJ Casey , ST Tonev , MC Davidson , AL Reiss , A Garrett , SP Hinshaw , LL Greenhill , G Glover , KM Shafritz , A Vitolo , LA Kotler , MA Jarrett , J Spicer (2007). ADHD- and medication-related brain activation effects in concordantly affected parent–child dyads with ADHD. Journal of Child Psychology and Psychiatry 48, 899–913.
SH Evans , EJ Anastasio (1968). Misuse of analysis of covariance when treatment effect and covariate are confounded. Psychological Bulletin 69, 225–234.
JD Gallezot , D Weinzimmer , N Nabulsi , SF Lin , K Fowles , C Sandiego , TJ McCarthy , RP Maguire , RE Carson , YS Ding (2011). Evaluation of [11C]MRB for assessment of occupancy of norepinephrine transporters: studies with atomoxetine in non-human primates. Neuroimage 56, 268–279.
NJ Gamo , M Wang , AF Arnsten (2010). Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors. Journal of the American Academy of Child and Adolescent Psychiatry 49, 1011–1023.
SS Gau , CY Shang (2010). Executive functions as endophenotypes in ADHD: evidence from the Cambridge Neuropsychological Test Battery (CANTAB). Journal of Child Psychology and Psychiatry 51, 838–849.
CE Ginestet , A Simmons (2011). Statistical parametric network analysis of functional connectivity dynamics during a working memory task. Neuroimage 55, 688–704.
SD Glick , DA Ross , LB Hough (1982). Lateral asymmetry of neurotransmitters in human brain. Brain Research 234, 53–63.
MC Goldberg , SH Mostofsky , LE Cutting , EM Mahone , BC Astor , MB Denckla , RJ Landa (2005). Subtle executive impairment in children with autism and children with ADHD. Journal of Autism and Developmental Disorders 35, 279–293.
R Goodman , S Scott (1999). Comparing the Strengths and Difficulties Questionnaire and the Child Behavior Checklist: is small beautiful? Journal of Abnormal Child Psychology 27, 17–24.
H Graf , B Abler , R Freudenmann , P Beschoner , E Schaeffeler , M Spitzer , M Schwab , G Gron (2011). Neural correlates of error monitoring modulated by atomoxetine in healthy volunteers. Biological Psychiatry 69, 890–897.
LL Greenhill , JM Swanson , B Vitiello , M Davies , W Clevenger , M Wu , LE Arnold , HB Abikoff , OG Bukstein , CK Conners , GR Elliott , L Hechtman , SP Hinshaw , B Hoza , PS Jensen , HC Kraemer , JS March , JH Newcorn , JB Severe , K Wells , T Wigal (2001). Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. Journal of the American Academy of Child and Adolescent Psychiatry 40, 180–187.
J Hannestad , JD Gallezot , B Planeta-Wilson , SF Lin , WA Williams , CH van Dyck , RT Malison , RE Carson , YS Ding (2010). Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo. Biological Psychiatry 68, 854–860.
H Hart , J Radua , D Mataix-Cols , K Rubia (2012). Meta-analysis of fMRI studies of timing in attention-deficit hyperactivity disorder (ADHD). Neuroscience and Biobehavioral Reviews 36, 2248–2256.
H Hart , J Radua , T Nakao , D Mataix-Cols , K Rubia (2013). Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. JAMA Psychiatry 70, 185–198.
PL Hazell , MR Kohn , R Dickson , RJ Walton , RE Granger , GW van Wyk (2010). Core ADHD symptom improvement with atomoxetine versus methylphenidate: a direct comparison meta-analysis. Journal of Attention Disorders 15, 674–683.
C Klein , K Wendling , P Huettner , H Ruder , M Peper (2006). Intra-subject variability in attention-deficit hyperactivity disorder. Biological Psychiatry 60, 1088–1097.
M Kobel , N Bechtel , P Weber , K Specht , M Klarhofer , K Scheffler , K Opwis , IK Penner (2009). Effects of methylphenidate on working memory functioning in children with attention deficit/hyperactivity disorder. European Journal of Paediatric Neurology 13, 516–523.
JL Lancaster , LH Rainey , JL Summerlin , CS Freitas , PT Fox , AC Evans , AW Toga , JC Mazziotta (1997). Automated labeling of the human brain: a preliminary report on the development and evaluation of a forward-transform method. Human Brain Mapping 5, 238–242.
JL Lancaster , MG Woldorff , LM Parsons , M Liotti , CS Freitas , L Rainey , PV Kochunov , D Nickerson , SA Mikiten , PT Fox (2000). Automated Talairach atlas labels for functional brain mapping. Human Brain Mapping 10, 120–131.
SM Landau , R Lal , JP O'Neil , S Baker , WJ Jagust (2009). Striatal dopamine and working memory. Cerebral Cortex 19, 445–454.
EB Liddle , C Hollis , MJ Batty , MJ Groom , JJ Totman , M Liotti , G Scerif , PF Liddle (2010). Task-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate. Journal of Child Psychology and Psychiatry 52, 761–771.
M Lijffijt , JL Kenemans , A ter Wal , EH Quik , C Kemner , H Westenberg , MN Verbaten , H van Engeland (2006). Dose-related effect of methylphenidate on stopping and changing in children with attention-deficit/hyperactivity disorder. European Psychiatry 21, 544–547.
AF Marquand , S De Simoni , OG O'Daly , SC Williams , J Mourao-Miranda , MA Mehta (2011). Pattern classification of working memory networks reveals differential effects of methylphenidate, atomoxetine, and placebo in healthy volunteers. Neuropsychopharmacology 36, 1237–1247.
R Martinussen , J Hayden , S Hogg-Johnson , R Tannock (2005). A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 44, 377–384.
JN Matthews , DG Altman (1996). Statistics notes. Interaction 2: compare effect sizes not P values. British Medical Journal 313, 808.
KR Merikangas , JP He , D Brody , PW Fisher , K Bourdon , DS Koretz (2010). Prevalence and treatment of mental disorders among US children in the 2001–2004 NHANES. Pediatrics 125, 75–81.
G Miller , J Chapman (2001). Misunderstanding analysis of covariance. Journal of Abnormal Psychology 110, 40–48.
N Modi , B Lindemulder , S Gupta (2000). Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation. Journal of Clinical Pharmacology 40, 379–388.
A Montoya , A Hervas , E Cardo , J Artigas , MJ Mardomingo , JA Alda , X Gastaminza , MJ Garcia-Polavieja , I Gilaberte , R Escobar (2009). Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naive children and adolescents with attention deficit/hyperactivity disorder. Current Medical Research and Opinion 25, 2745–2754.
T Nakao , J Radua , K Rubia , D Mataix-Cols (2011). Gray matter volume abnormalities in ADHD and the effects of stimulant medication: voxel-based meta-analysis. American Journal of Psychiatry 168, 1154–1163.
AM Owen , KM McMillan , AR Laird , E Bullmore (2005). N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies. Human Brain Mapping 25, 46–59.
A Pasini , C Paloscia , R Alessandrelli , MC Porfirio , P Curatolo (2007). Attention and executive functions profile in drug naive ADHD subtypes. Brain and Development 29, 400–408.
A Prehn-Kristensen , K Krauel , H Hinrichs , J Fischer , U Malecki , H Schuetze , S Wolff , O Jansen , E Duezel , L Baving (2011). Methylphenidate does not improve interference control during a working memory task in young patients with attention-deficit hyperactivity disorder. Brain Research 1388, 56–68.
SM Rhodes , J Park , S Seth , DR Coghill (2011). A comprehensive investigation of memory impairment in attention deficit hyperactivity disorder and oppositional defiant disorder. Journal of Child Psychology and Psychiatry 53, 128–137.
K Rubia (2011). ‘Cool’ inferior fronto-striatal dysfunction in attention-deficit hyperactivity disorder (ADHD) versus ‘hot’ ventromedial orbitofronto-limbic dysfunction in conduct disorder: a review. Biological Psychiatry 69, e69–e87.
K Rubia , R Halari , A Christakou , E Taylor (2009 a). Impulsiveness as a timing disturbance: neurocognitive abnormalities in attention-deficit hyperactivity disorder during temporal processes and normalization with methylphenidate. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 364, 1919–1931.
K Rubia , R Halari , A Cubillo , AM Mohammad , M Brammer , E Taylor (2011 a). Methylphenidate normalises fronto-striatal underactivation during interference inhibition in medication-naive children with attention-deficit hyperactivity disorder. Neuropsychopharmacology 36, 1575–1586.
K Rubia , R Halari , A Cubillo , M Mohammad , E Taylor (2009 b). Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naive children with ADHD during a Rewarded Continuous Performance Task. Neuropharmacology 57, 640–652.
K Rubia , R Halari , AM Mohammad , E Taylor , M Brammer (2011 b). Methylphenidate normalises fronto-cingulate underactivation during error processing in attention-deficit hyperactivity disorder. Biological Psychiatry 70, 255–262.
J-M Sauer , GD Ponsler , EL Mattiuz , AJ Long , JW Witcher , HR Thomasson , KA Desante (2003). Disposition and metabolic fate of atomoxetine hydrochloride: the role of CYP2D6 in human disposition and metabolism. Drug Metabolism and Disposition 31, 98–107.
KM Shafritz , KE Marchione , JC Gore , SE Shaywitz , BA Shaywitz (2004). The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder. American Journal of Psychiatry 161, 1990–1997.
MA Sheridan , S Hinshaw , M D'Esposito (2010). Stimulant medication and prefrontal functional connectivity during working memory in ADHD: a preliminary report. Journal of Attention Disorders 14, 69–78.
T Silk , A Vance , N Rinehart , G Egan , M O'Boyle , JL Bradshaw , R Cunnington (2005). Fronto-parietal activation in attention-deficit hyperactivity disorder, combined type: functional magnetic resonance imaging study. British Journal of Psychiatry 187, 282–283.
A Simmons , E Moore , SC Williams (1999). Quality control for functional magnetic resonance imaging using automated data analysis and Shewhart charting. Magnetic Resonance in Medicine 41, 1274–1278.
M Toplak , U Jain , T Rosemary (2008). Executive and motivational processes in adolescents with attention-deficit-hyperactivity disorder (ADHD). Behavioural and Brain Functions 1, 8.
DM Tucker , PA Williamson (1984). Asymmetric neural control systems in human self-regulation. Psychological Review 91, 185–215.
CJ Vaidya , G Austin , G Kirkorian , HW Ridlehuber , JE Desmond , GH Glover , JDE Gabrieli (1998). Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proceedings of the National Academy of Sciences USA 95, 14494–14499.
EM Valera , A Brown , J Biederman , SV Faraone , N Makris , MC Monuteaux , S Whitfield-Gabrieli , M Vitulano , M Schiller , LJ Seidman (2010). Sex differences in the functional neuroanatomy of working memory in adults with ADHD. American Journal of Psychiatry 167, 87–94.
A Vance , TJ Silk , M Casey , NJ Rinehart , JL Bradshaw , MA Bellgrove , R Cunnington (2007). Right parietal dysfunction in children with attention deficit hyperactivity disorder, combined type: a functional MRI study. Molecular Psychiatry 12, 826–832.
ND Volkow , GJ Wang , JS Fowler , SJ Gatley , J Logan , YS Ding , R Hitzemann , N Pappas (1998). Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. American Journal of Psychiatry 155, 1325–1331.
EG Willcutt , AE Doyle , JT Nigg , SV Faraone , BF Pennington (2005). Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biological Psychiatry 57, 1336–1346.
JW Witcher , A Long , B Smith , JM Sauer , J Heilgenstein , T Wilens , T Spencer , J Biederman (2003). Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 13, 53–63.
CG Wong , MC Stevens (2012). The effects of stimulant medication on working memory functional connectivity in attention-deficit/hyperactivity disorder. Biological Psychiatry 71, 458–466.